This map shows the geographic impact of H.L. Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.L. Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.L. Atkins more than expected).
This network shows the impact of papers produced by H.L. Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.L. Atkins. The network helps show where H.L. Atkins may publish in the future.
Co-authorship network of co-authors of H.L. Atkins
This figure shows the co-authorship network connecting the top 25 collaborators of H.L. Atkins.
A scholar is included among the top collaborators of H.L. Atkins based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with H.L. Atkins. H.L. Atkins is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
19 of 19 papers shown
1.
Srivastava, S.C., H.L. Atkins, Gerbail T. Krishnamurthy, et al.. (1998). Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.. PubMed. 4(1). 61–8.62 indexed citations
Shreeve, Walton W., et al.. (1987). Phantom gallbladder. A variant of the rim sign.. PubMed. 12(6). 457–60.7 indexed citations
4.
Reivich, M., Joel Greenberg, A.P. Wolf, et al.. (1984). The evaluation of the lumped constant for deoxyglucose and fluorodeoxyglucose in man. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information).1 indexed citations
Gallagher, Brian M., A.N. Ansari, H.L. Atkins, et al.. (1977). Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(10). 990–6.151 indexed citations
Ansari, A.N., et al.. (1975). Note on the distribution of iodine-123-labeled indocyanine green in the eye. XVIII.. PubMed. 14(10). 780–2.1 indexed citations
10.
Lambrecht, Richard M., et al.. (1974). A novel 123I-labeling reagent. XIII. Synthesis and loading-dose effects of 123I-iodophenylalanine and 123I-5- and6-iodotryptophan.. PubMed. 15(10). 863–7.12 indexed citations
11.
Atkins, H.L., Ralph G. Fairchild, & Ruth M. Drew. (1973). BIOLOGICAL PROPERTIES OF 252CF. American Journal of Roentgenology. 117(3). 704–710.8 indexed citations
12.
Atkins, H.L., et al.. (1972). Organic radiopharmaceuticals labeled with isotopes of short half-life. V. 18 F-labeled 5- and 6-fluorotryptophan.. PubMed. 13(10). 713–9.39 indexed citations
13.
Robertson, James S., Ralph G. Fairchild, & H.L. Atkins. (1972). Dosimetry of Californium 252. Radiology. 104(2). 393–398.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.